Browsing by Author Yasaei, H

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 5 to 14 of 14 < previous 
Issue DateTitleAuthor(s)
2010Defective Artemis causes mild telomere dysfunctionYasaei, H; Slijepcevic, P
2015Disruptive chemicals, senescence and immortalityCarnero, A; Blanco-Aparicio, C; Kondoh, H; Lleonart, ME; Martinez-Leal, JF, et al
2014The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell linesMotevalli, A; Yasaei, H; Virmouni, SA; Slijepcevic, P; Roberts, T
2011Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cellsSapir, E; Gozaly-Chianea, Y; Al-Wahiby, S; Ravindran, S; Yasaei, H, et al
2017Functional and prognostic significance of the genomic amplification of frizzled receptor 6 ( FZD6 ) in breast cancerCorda, G; Sala, G; Lattanzio, R; Iezzi, M; Sallese, M, et al
2017Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expressionLinne, H; Yasaei, H; Marriott, A; Harvey, A; Mokbel, K, et al
2013Genotype and phenotype characterisation of Friedreich ataxia mouse models and cellsPook, M; Slijepcevic, P; Eskiw, C; Al-Mahdawi, S; Roberts, T, et al
2015Identification of telomere dysfunction in Friedreich ataxiaAnjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P, et al
2015Identification of telomere dysfunction in Friedreich ataxia.Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, S; Yasaei, H; Giunti, P, et al
2016Telomere elongation in the breast cancer cell line 21NT after treatment with an epigenetic modifying drugMotevalli, A; Yasaei, H; Virmouni, SA; Mirabdulhagh, M; Slijepcevic, P, et al